Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1344/week)
    • Manufacturing(682/week)
    • Energy(551/week)
    • Technology(1197/week)
    • Other Manufacturing(492/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Esters

May 18, 2020
Global & Chinese Ethyl Methyl Carbonate Market Insights 2020 - ResearchAndMarkets.com
Mar 31, 2020
Global Sucrose Esters Market Outlook to 2027 - ResearchAndMarkets.com
Feb 28, 2020
Global Sustainable Aviation Fuel (SAF) Industry to Witness a CAGR of 24.33% During 2020-2028 - Hydro Treated Esters & Fatty Acids (HEFAs) are the Fastest-Growing Production Technology
Feb 28, 2020
Global Sustainable Aviation Fuel (SAF) Industry to Witness a CAGR of 24.33% During 2020-2028 - Hydro Treated Esters & Fatty Acids (HEFAs) are the Fastest-Growing Production Technology
Feb 13, 2020
Global Dimethyl Carbonate Market Analysis & Trends (2018 to 2028) - Featuring Merck KGaA, Lotte Chemical, Kowa Company & Kishida Chemical Co Among Others - ResearchAndMarkets.com
Feb 10, 2020
Global Sucrose Esters Market Size is Projected to Grow from USD 76 Million in 2019 to USD 106 Million by 2025 - ResearchAndMarkets.com
Jul 10, 2019
FDA Approves Katerzia(TM), the First and Only Amlodipine Oral Suspension, 1 mg/mL, for Pediatric Patients 6 Years of Age and Older
Jun 19, 2019
Global HIV Disease Coverage Forecast and Market 2019-2024: B/F/TAF will Drive Significant Revenue Growth Due to its Attractive Combination of an INSTI and a Preferred Backbone
Apr 19, 2019
Mass Tort Alleges Gilead Sciences, Inc. Withheld Safer Drugs From HIV/AIDS Patients, Manipulated Patent Timing for Profit, Announces Jenner Law
Mar 25, 2019
Slayback Pharma announces approval of Hydroxyprogesterone Caproate Injection, USP 250 mg/ 1 mL in a single-dose vial, generic equivalent of Makena® Injection 250 mg/ 1 mL
Jan 21, 2019
Slayback Pharma announces launch of Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 mL in a multi-dose vial, the first generic equivalent of Makena® Injection 1,250 mg/ 5 mL multi-dose vial

Latest News

Aug 12, 2025

Lifezone Metals Reports Half-Year 2025 Financial Results

Aug 12, 2025

Newmont Corporation Announces Pricing of its Tender Offers for $2 billion of Certain Outstanding Series of...

Aug 12, 2025

Net Power Reports Second Quarter 2025 Results and Provides Business Update

Aug 12, 2025

BigBear.ai Announces Second Quarter 2025 Results; Updates Financial Outlook

Aug 12, 2025

Archer Announces Second Quarter Results, Highlighting Manufacturing Ramp Of Midnight Aircraft Ahead Of Early...

Aug 12, 2025

Celanese Corporation Reports Second Quarter Earnings

Aug 12, 2025

Armed Forces Benefit Association Appoints Joseph P. Stangl Chief Financial Officer

Aug 12, 2025

Alloy Roofing Partners with Tittle Brothers Construction in Brownstown Township, MI

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia